Cargando…
Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review
It is over 50 years since the discovery of microtubules, and they have become one of the most important drug targets for anti-cancer therapies. Microtubules are predominantly composed of the protein tubulin, which contains a number of different binding sites for small-molecule drugs. There is contin...
Autores principales: | McLoughlin, Eavan C., O’Boyle, Niamh M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168938/ https://www.ncbi.nlm.nih.gov/pubmed/31947889 http://dx.doi.org/10.3390/ph13010008 |
Ejemplares similares
-
Correction: McLoughlin, E.C.; O’Boyle, N.M. Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review. Pharmaceuticals 2020, 13, 8
por: McLoughlin, Eavan C., et al.
Publicado: (2020) -
Application of 2D EXSY and qNMR Spectroscopy for Diastereomeric Excess Determination Following Chiral Resolution of β‐Lactams
por: McLoughlin, Eavan C., et al.
Publicado: (2022) -
Synthesis, Characterisation and Mechanism of Action of Anticancer 3-Fluoroazetidin-2-ones
por: Malebari, Azizah M., et al.
Publicado: (2022) -
Recent Advances of Tubulin Inhibitors Targeting the Colchicine Binding Site for Cancer Therapy
por: Hawash, Mohammed
Publicado: (2022) -
Potent Quinoline-Containing Combretastatin A-4 Analogues: Design, Synthesis, Antiproliferative, and Anti-Tubulin Activity
por: Ibrahim, Tarek S., et al.
Publicado: (2020)